Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin vs Duloxetine for Painful Diabetic Peripheral Neuropathy
NCT07882238Phase 2Not yet recruiting
- Sponsor
- Assiut University
- Start
- Nov 2026
- Primary completion
- Nov 2027
01
Overview
A Phase 2 trial of botulinum toxin type A in diabetic peripheral neuropathy (DPN), sponsored by Assiut University. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT07882238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07882238.